Angelisa Frasca

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Oxidative Stress

Autism Spectrum Disorder

Top Venues

EMBO molecular medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Angelisa Frasca, Federica Miramondi, Erica Butti, Marzia Indrigo, Maria Balbontin Arenas, Francesca M Postogna, Arianna Piffer, Francesco Bedogni, Lara Pizzamiglio, Clara Cambria, Ugo Borello, Flavia Antonucci, Gianvito Martino, Nicoletta Landsberger
Neural precursor cells rescue symptoms of Rett syndrome by activation of the Interferon γ pathway. EMBO molecular medicine (2024)
Clara Rossi, Marco Venturin, Jakub Gubala, Angelisa Frasca, Alberto Corsini, Cristina Battaglia, Stefano Bellosta
PURPL and NEAT1 Long Non-Coding RNAs Are Modulated in Vascular Smooth Muscle Cell Replicative Senescence. Biomedicines 11 (12) (2023)
Sabrina Briguglio, Clara Cambria, Elena Albizzati, Elena Marcello, Giovanni Provenzano, Angelisa Frasca, Flavia Antonucci
New Views of the DNA Repair Protein Ataxia-Telangiectasia Mutated in Central Neurons: Contribution in Synaptic Dysfunctions of Neurodevelopmental and Neurodegenerative Diseases. Cells 12 (17) (2023)
Clara Rossi, Marco Venturin, Jakub Gubala, Angelisa Frasca, Alberto Corsini, Cristina Battaglia, Stefano Bellosta
PURPL and NEAT1 Long Non-Coding RNAs Are Modulated in Vascular Smooth Muscle Cell Replicative Senescence. Biomedicines 11 (12) (2023)
Angelisa Frasca, Eleonora Spiombi, Michela Palmieri, Elena Albizzati, Maria Maddalena Valente, Anna Bergo, Barbara Leva, Charlotte Kilstrup-Nielsen, Federico Bianchi, Valerio Di Carlo, Ferdinando Di Cunto, Nicoletta Landsberger
MECP2 mutations affect ciliogenesis: a novel perspective for Rett syndrome and related disorders. EMBO molecular medicine 12 (6) (2020)
Dario Balestra, Domenico Giorgio, Matteo Bizzotto, Sandro Sonnino, Bruria Ben Zeev, Mirko Pinotti, Nicoletta Landsberger, Angelisa Frasca
Splicing Mutations Impairing CDKL5 Expression and Activity Can be Efficiently Rescued by U1snRNA-Based Therapy. International journal of molecular sciences 20 (17) (2019)